RARECAREnet Event: Rare Cancers In Belgium
An ECPC, RARECAREnet and Belgian Cancer Registry event: Quality of care for rare cancers in Belgium, 16 April 2015
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
An ECPC, RARECAREnet and Belgian Cancer Registry event: Quality of care for rare cancers in Belgium, 16 April 2015
Bortezomib based therapy effective in patients with newly diagnosed mantle-cell lymphoma, an incurable, aggressive haematological malignancy
Save the date: Workshop in Brussels on March 24 2015 to explore how European Reference Networks (ERNs) can help find solutions for the unique needs of rare cancer patients
Rare Disease Day 2015 seeks to raise awareness of the challenges faced by patients and their families
'Success with orphan drugs needn't be rare'
Offering a new treatment paradigm for a group of patients for whom, until recently, there has been no new effective treatment since the 1940s.
The trial plans to assess the efficacy of maintenance treatment with cabozantinib
Building a global consensus approach to chordoma: a position paper from the medical and patient community
An article from EURODIS explaining why we need ERNs
A consensus paper published in Annals of Oncology by Rare Cancers Europe (RCE), calls for new methodologies to be applied to clinical studies in rare cancers
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.